Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 2.870
+0.020 (0.70%)
At close: Dec 4, 2025
Indies Pharma Jamaica Revenue
Indies Pharma Jamaica had revenue of 260.04M JMD in the quarter ending July 31, 2025, a decrease of -12.29%. This brings the company's revenue in the last twelve months to 1.15B, up 1.04% year-over-year. In the fiscal year ending October 31, 2024, Indies Pharma Jamaica had annual revenue of 1.16B with 9.81% growth.
Revenue (ttm)
1.15B
Revenue Growth
+1.04%
P/S Ratio
3.33
Revenue / Employee
17.66M
Employees
65
Market Cap
3.82B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scotia Group Jamaica | 64.10B |
| Sagicor Group Jamaica | 113.24B |
| NCB Financial Group | 144.29B |
| Caribbean Cement Company | 30.82B |
| Barita Investments | 8.02B |
| Pan Jamaica Group | 49.63B |
| Carreras | 22.20B |
| Seprod | 153.23B |